Eli Lilly and Company

Embracing the Power of Diversity at Lilly

by LillyPad

Today’s guest blog comes from Lilly’s Chief Diversity Officer, Monique Hunt McWilliams.

DiversityInc revealed this week what I already know: Lilly stands out as a company embracing and valuing diversity. For the fifth year in a row, we have been named to DiversityInc's Top 50 Companies for Diversity list.

Lilly: Announcing the 2015 REACH Lilly MDR TB Partnership Media Award Winners


Today’s guest blog comes from Sunita Prasad, senior manager for Lilly’s MDR-TB Partnership in India.

Tuberculosis (TB) continues to pose a monumental global health challenge. The disease affected nine million people in 2013, and claimed 1.5 million lives. In India, 1,000 people die of TB daily, though the disease is fully curable.

Lilly: Forging Alliances is Crucial to Fighting Tuberculosis


Today’s guest Blogger is Dr. Lasha Goguadze, Senior Health Officer, Global Tuberculosis Programme, International Federation of the Red Cross and Red Crescent Societies. He is based in Geneva.

Lilly: Women in the Workplace - A Culture of Inclusion


Today’s guest post comes from Monique Hunt McWilliams, Eli Lilly and Company’s Chief Diversity officer.

Lilly Foundation Furthers Commitment to Education


Taking steps to improve the educational opportunities available to all of the children in our hometown of Indianapolis is a key area of focus for Lilly.  In recent months, we have advocated for the growth of early education opportunities in our home city and advanced our partnership with Indianapolis Public Schools by joining the IPS Business Alliance.

Lilly: Eyes to See, Hearts to Care


Amazing. That’s how Karen Wurster with Lilly Diabetes describes her experience as a volunteer with the Lilly NCD Partnership in India last fall.

Karen has devoted most of her career to helping people with diabetes. But after serving as a Connecting Hearts Abroad ambassador in a rural village north of Delhi, the eyes of this seasoned diabetes professional were opened wider as she viewed the unique challenges of managing this chronic disease through a different lens.

Lilly: Fight for Your Life, No Matter Where You Live


Today’s guest blog, on World Cancer Day, comes from Lilly’s senior vice president and president of Lilly Oncology, Sue Mahony, Ph.D.

Imagine you’re a young woman who has just been diagnosed with cancer. Your mind rushes to the impact on your children, your husband. For them, you know you will fight to survive. You will request a second opinion. You will ask friends and co-workers for recommendations for the best oncologist. You will research online to find a premier cancer treatment facility. You will demand the best medicines available.

Lilly: Drug-Resistant TB Demands More R&D


Today's guest blog comes from Lilly's vice president of Global Health Programs, Evan Lee, M.D. 

A new article published by a team from the World Health Organization in the European Respiratory Journal shows that while we’re seeing gradual expansion in care for multidrug-resistant TB (MDR-TB), there continues to be an urgent need to accelerate the scale up of diagnosis and treatment efforts in heavily affected countries. 

Lilly: An Unexpected Global Health Threat


If someone asked you to characterize the biggest global health crisis in low and middle income countries, would non-communicable diseases (NCDs) come to mind? Probably not. With headlines focusing on infectious diseases like Ebola or influenza, the damaging societal effect of chronic diseases can get lost. In fact, NCDs like heart disease, diabetes, and cancer have the greatest impact on economic stability, governance, and workforce productivity. 

Lilly: Continuing Our Legacy of Community Involvement


Corporate responsibility is woven into the fabric of Lilly. It defines how we think and act, permeates all of our business areas, and is a vital part of our heritage.


Subscribe to Eli Lilly and Company